Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Cell-Free DNA (cfDNA) Testing Market Size Analysis from 2022 to 2027

1.5.1 Global Cell-Free DNA (cfDNA) Testing Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Cell-Free DNA (cfDNA) Testing Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Cell-Free DNA (cfDNA) Testing Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Cell-Free DNA (cfDNA) Testing Industry Impact

Chapter 2 Global Cell-Free DNA (cfDNA) Testing Competition by Types, Applications, and Top Regions and Countries

2.1 Global Cell-Free DNA (cfDNA) Testing (Volume and Value) by Type

2.1.1 Global Cell-Free DNA (cfDNA) Testing Consumption and Market Share by Type (2016-2021)

2.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue and Market Share by Type (2016-2021)

2.2 Global Cell-Free DNA (cfDNA) Testing (Volume and Value) by Application

2.2.1 Global Cell-Free DNA (cfDNA) Testing Consumption and Market Share by Application (2016-2021)

2.2.2 Global Cell-Free DNA (cfDNA) Testing Revenue and Market Share by Application (2016-2021)

2.3 Global Cell-Free DNA (cfDNA) Testing (Volume and Value) by Regions

2.3.1 Global Cell-Free DNA (cfDNA) Testing Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Cell-Free DNA (cfDNA) Testing Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Cell-Free DNA (cfDNA) Testing Consumption by Regions (2016-2021)

4.2 North America Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

4.10 South America Cell-Free DNA (cfDNA) Testing Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Cell-Free DNA (cfDNA) Testing Market Analysis

5.1 North America Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

5.1.1 North America Cell-Free DNA (cfDNA) Testing Market Under COVID-19

5.2 North America Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

5.3 North America Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

5.4 North America Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

5.4.1 United States Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

5.4.2 Canada Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

5.4.3 Mexico Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 6 East Asia Cell-Free DNA (cfDNA) Testing Market Analysis

6.1 East Asia Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

6.1.1 East Asia Cell-Free DNA (cfDNA) Testing Market Under COVID-19

6.2 East Asia Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

6.3 East Asia Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

6.4 East Asia Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

6.4.1 China Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

6.4.2 Japan Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

6.4.3 South Korea Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 7 Europe Cell-Free DNA (cfDNA) Testing Market Analysis

7.1 Europe Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

7.1.1 Europe Cell-Free DNA (cfDNA) Testing Market Under COVID-19

7.2 Europe Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

7.3 Europe Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

7.4 Europe Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

7.4.1 Germany Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.2 UK Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.3 France Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.4 Italy Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.5 Russia Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.6 Spain Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.7 Netherlands Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.8 Switzerland Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

7.4.9 Poland Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 8 South Asia Cell-Free DNA (cfDNA) Testing Market Analysis

8.1 South Asia Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

8.1.1 South Asia Cell-Free DNA (cfDNA) Testing Market Under COVID-19

8.2 South Asia Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

8.3 South Asia Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

8.4 South Asia Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

8.4.1 India Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

8.4.2 Pakistan Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Analysis

9.1 Southeast Asia Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

9.1.1 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Under COVID-19

9.2 Southeast Asia Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

9.3 Southeast Asia Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

9.4 Southeast Asia Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

9.4.1 Indonesia Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

9.4.2 Thailand Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

9.4.3 Singapore Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

9.4.4 Malaysia Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

9.4.5 Philippines Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

9.4.6 Vietnam Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

9.4.7 Myanmar Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 10 Middle East Cell-Free DNA (cfDNA) Testing Market Analysis

10.1 Middle East Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

10.1.1 Middle East Cell-Free DNA (cfDNA) Testing Market Under COVID-19

10.2 Middle East Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

10.3 Middle East Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

10.4 Middle East Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

10.4.1 Turkey Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.3 Iran Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.5 Israel Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.6 Iraq Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.7 Qatar Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.8 Kuwait Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

10.4.9 Oman Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 11 Africa Cell-Free DNA (cfDNA) Testing Market Analysis

11.1 Africa Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

11.1.1 Africa Cell-Free DNA (cfDNA) Testing Market Under COVID-19

11.2 Africa Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

11.3 Africa Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

11.4 Africa Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

11.4.1 Nigeria Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

11.4.2 South Africa Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

11.4.3 Egypt Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

11.4.4 Algeria Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

11.4.5 Morocco Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 12 Oceania Cell-Free DNA (cfDNA) Testing Market Analysis

12.1 Oceania Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

12.2 Oceania Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

12.3 Oceania Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

12.4 Oceania Cell-Free DNA (cfDNA) Testing Consumption by Top Countries

12.4.1 Australia Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

12.4.2 New Zealand Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 13 South America Cell-Free DNA (cfDNA) Testing Market Analysis

13.1 South America Cell-Free DNA (cfDNA) Testing Consumption and Value Analysis

13.1.1 South America Cell-Free DNA (cfDNA) Testing Market Under COVID-19

13.2 South America Cell-Free DNA (cfDNA) Testing Consumption Volume by Types

13.3 South America Cell-Free DNA (cfDNA) Testing Consumption Structure by Application

13.4 South America Cell-Free DNA (cfDNA) Testing Consumption Volume by Major Countries

13.4.1 Brazil Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.2 Argentina Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.3 Columbia Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.4 Chile Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.5 Venezuela Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.6 Peru Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

13.4.8 Ecuador Cell-Free DNA (cfDNA) Testing Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Cell-Free DNA (cfDNA) Testing Business

14.1 Agilent Technology

14.1.1 Agilent Technology Company Profile

14.1.2 Agilent Technology Cell-Free DNA (cfDNA) Testing Product Specification

14.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Invited

14.2.1 Invited Company Profile

14.2.2 Invited Cell-Free DNA (cfDNA) Testing Product Specification

14.2.3 Invited Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Biodesix

14.3.1 Biodesix Company Profile

14.3.2 Biodesix Cell-Free DNA (cfDNA) Testing Product Specification

14.3.3 Biodesix Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Allenex

14.4.1 Allenex Company Profile

14.4.2 Allenex Cell-Free DNA (cfDNA) Testing Product Specification

14.4.3 Allenex Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Illumania

14.5.1 Illumania Company Profile

14.5.2 Illumania Cell-Free DNA (cfDNA) Testing Product Specification

14.5.3 Illumania Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Biocept

14.6.1 Biocept Company Profile

14.6.2 Biocept Cell-Free DNA (cfDNA) Testing Product Specification

14.6.3 Biocept Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Quest Diagnostics

14.7.1 Quest Diagnostics Company Profile

14.7.2 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Specification

14.7.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Guardant Health

14.8.1 Guardant Health Company Profile

14.8.2 Guardant Health Cell-Free DNA (cfDNA) Testing Product Specification

14.8.3 Guardant Health Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 CareDx

14.9.1 CareDx Company Profile

14.9.2 CareDx Cell-Free DNA (cfDNA) Testing Product Specification

14.9.3 CareDx Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Natera

14.10.1 Natera Company Profile

14.10.2 Natera Cell-Free DNA (cfDNA) Testing Product Specification

14.10.3 Natera Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Roche Holdings

14.11.1 Roche Holdings Company Profile

14.11.2 Roche Holdings Cell-Free DNA (cfDNA) Testing Product Specification

14.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Sequenom

14.12.1 Sequenom Company Profile

14.12.2 Sequenom Cell-Free DNA (cfDNA) Testing Product Specification

14.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Trovagene

14.13.1 Trovagene Company Profile

14.13.2 Trovagene Cell-Free DNA (cfDNA) Testing Product Specification

14.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Cell-Free DNA (cfDNA) Testing Market Forecast (2022-2027)

15.1 Global Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Cell-Free DNA (cfDNA) Testing Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Cell-Free DNA (cfDNA) Testing Value and Growth Rate Forecast (2022-2027)

15.2 Global Cell-Free DNA (cfDNA) Testing Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Cell-Free DNA (cfDNA) Testing Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Cell-Free DNA (cfDNA) Testing Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Cell-Free DNA (cfDNA) Testing Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Cell-Free DNA (cfDNA) Testing Consumption Forecast by Type (2022-2027)

15.3.2 Global Cell-Free DNA (cfDNA) Testing Revenue Forecast by Type (2022-2027)

15.3.3 Global Cell-Free DNA (cfDNA) Testing Price Forecast by Type (2022-2027)

15.4 Global Cell-Free DNA (cfDNA) Testing Consumption Volume Forecast by Application (2022-2027)

15.5 Cell-Free DNA (cfDNA) Testing Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology